(Q82913717)
Statements
Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials (English)
Guanghui Gao
Shengxiang Ren
Aiwu Li
Jianfang Xu
Qinghua Xu
Chunxia Su
Jian Guo
Qinfang Deng